Type 2 cytokines: mechanisms and therapeutic strategies - PubMed (original) (raw)

Review

doi: 10.1038/nri3831. Epub 2015 Apr 17.

Affiliations

Review

Type 2 cytokines: mechanisms and therapeutic strategies

Thomas A Wynn. Nat Rev Immunol. 2015 May.

Abstract

Type 2 immune responses are defined by the cytokines interleukin-4 (IL-4), IL-5, IL-9 and IL-13, which can either be host protective or have pathogenic activity. Type 2 immunity promotes antihelminth immunity, suppresses type 1-driven autoimmune disease, neutralizes toxins, maintains metabolic homeostasis, and regulates wound repair and tissue regeneration pathways following infection or injury. Nevertheless, when type 2 responses are dysregulated, they can become important drivers of disease. Type 2 immunity induces a complex inflammatory response characterized by eosinophils, mast cells, basophils, type 2 innate lymphoid cells, IL-4-and/or IL-13-conditioned macrophages and T helper 2 (TH2) cells, which are crucial to the pathogenesis of many allergic and fibrotic disorders. As chronic type 2 immune responses promote disease, the mechanisms that regulate their maintenance are thought to function as crucial disease modifiers. This Review discusses the many endogenous negative regulatory mechanisms that antagonize type 2 immunity and highlights how therapies that target some of these pathways are being developed to treat type 2-mediated disease.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 2002 Mar 1;168(5):2383-92 - PubMed
    1. Nat Immunol. 2001 Aug;2(8):725-31 - PubMed
    1. Immunity. 2008 Apr;28(4):477-87 - PubMed
    1. Expert Opin Biol Ther. 2014 Feb;14 (2):165-81 - PubMed
    1. J Immunol. 1996 Nov 15;157(10):4602-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources